Antipodean Advisors LLC - Q3 2017 holdings

$118 Million is the total value of Antipodean Advisors LLC's 11 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 68.8% .

 Value Shares↓ Weighting
EXAS BuyEXACT SCIENCES CORP$27,205,000
+61.5%
577,346
+21.2%
22.96%
+142.3%
CHTR BuyCHARTER COMMUNICATIONS INC Ncl a$22,532,000
+30.4%
62,000
+20.9%
19.02%
+95.6%
BABA NewALIBABA GROUP HLDG LTDsponsored ads$15,026,00087,000
+100.0%
12.68%
DXC SellDXC TECHNOLOGY CO$9,962,000
+10.0%
116,000
-1.7%
8.41%
+65.1%
BAC SellBANK AMER CORP$9,198,000
-42.3%
363,000
-44.7%
7.76%
-13.4%
A NewAGILENT TECHNOLOGIES INC$8,603,000134,000
+100.0%
7.26%
CFCO  CF CORP$8,288,000
-0.4%
740,0000.0%6.99%
+49.4%
MDCO SellMEDICINES CO$6,519,000
-70.1%
176,000
-69.4%
5.50%
-55.2%
AMZN SellAMAZON COM INC$5,720,000
-69.3%
5,950
-69.1%
4.83%
-53.9%
IAC NewIAC INTERACTIVECORP$3,763,00032,000
+100.0%
3.18%
NG  NOVAGOLD RES INC$1,681,000
-9.6%
408,0000.0%1.42%
+35.7%
ATUS ExitALTICE USA INCcl a$0-5,000
-100.0%
-0.09%
GPRO ExitGOPRO INCcl a$0-71,000
-100.0%
-0.32%
SCI ExitSERVICE CORP INTL$0-67,000
-100.0%
-1.26%
PTC ExitPTC INC$0-122,000
-100.0%
-3.78%
LW ExitLAMB WESTON HLDGS INC$0-171,000
-100.0%
-4.24%
FB ExitFACEBOOK INCcl a$0-100,000
-100.0%
-8.49%
BIO ExitBIO RAD LABS INCcl a$0-75,000
-100.0%
-9.55%
SLM ExitSLM CORP$0-1,627,802
-100.0%
-10.53%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CARVANA CO21Q2 202338.5%
AMAZON COM INC20Q4 202033.8%
SEA LTD19Q3 202360.8%
CARDLYTICS INC18Q3 202326.3%
MEDICINES CO18Q4 201919.8%
ATARA BIOTHERAPEUTICS INC15Q3 202317.9%
CONSTELLATION BRANDS INC14Q4 201611.1%
HERBALIFE NUTRITION LTD13Q1 202124.8%
CLARIVATE PLC11Q4 202124.4%
EXACT SCIENCES CORP11Q2 201924.6%

View Antipodean Advisors LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Antipodean Advisors LLC Q3 2017 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Oncothyreon Inc.Sold outJanuary 09, 201300.0%

View Antipodean Advisors LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-13
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
13F-HR2021-11-15
13F-HR2021-08-16

View Antipodean Advisors LLC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (118496000.0 != 118497000.0)

Export Antipodean Advisors LLC's holdings